Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Langer

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Journal of Enzyme Inhibition|August 11, 2001
Potential of pyrazolooxadiazinone derivatives as serine protease inhibitorsC B Vicentini, M Guarneri, V Andrisano, et al.
Medical and Pediatric Oncology|August 1, 1997
CNS late effects after ALL therapy in childhood. Part II: Conventional EEG recordings in asymptomatic long-term survivors of childhood ALL--an evaluation of the interferences between neurophysiology, neurology, psychology, and CNS morphology. German Late Effects Working GroupM A Ueberall, D Wenzel, H Hertzberg, et al.
Endocrine Connections|July 28, 2022
The chance of transition: strategies for multidisciplinary collaborationJ Gebauer, R Skinner, R Haupt, et al.
Clinical Endocrinology|March 27, 2007
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance SystemM Paulides, H G Dörr, W Stöhr, et al.
Intensive Care Medicine|January 26, 2012
In vivo conditioning of acid-base equilibrium by crystalloid solutions: an experimental study on pigsT Langer, E Carlesso, A Protti, et al.
Mutation Research|July 24, 1998
Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagensS Knasmüller, W Parzefall, R Sanyal, et al.
Klinische Padiatrie|June 2, 2010
Immunity against tetanus and diphtheria after childhood sarcoma treatmentM Paulides, W Stöhr, H-Jürgen Laws, et al.
Medical and Pediatric Oncology|June 1, 1997
CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working GroupH Hertzberg, W J Huk, M A Ueberall, et al.
European Journal of Pediatrics|September 20, 1997
Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/BM A Ueberall, G Skirl, H M Strassburg, et al.
Journal of Medicinal Chemistry|March 26, 1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivativesA Cappelli, M Anzini, S Vomero, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Journal of Enzyme Inhibition|August 11, 2001
Potential of pyrazolooxadiazinone derivatives as serine protease inhibitorsC B Vicentini, M Guarneri, V Andrisano, et al.
Medical and Pediatric Oncology|August 1, 1997
CNS late effects after ALL therapy in childhood. Part II: Conventional EEG recordings in asymptomatic long-term survivors of childhood ALL--an evaluation of the interferences between neurophysiology, neurology, psychology, and CNS morphology. German Late Effects Working GroupM A Ueberall, D Wenzel, H Hertzberg, et al.
Endocrine Connections|July 28, 2022
The chance of transition: strategies for multidisciplinary collaborationJ Gebauer, R Skinner, R Haupt, et al.
Clinical Endocrinology|March 27, 2007
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance SystemM Paulides, H G Dörr, W Stöhr, et al.
Intensive Care Medicine|January 26, 2012
In vivo conditioning of acid-base equilibrium by crystalloid solutions: an experimental study on pigsT Langer, E Carlesso, A Protti, et al.
Mutation Research|July 24, 1998
Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagensS Knasmüller, W Parzefall, R Sanyal, et al.
Klinische Padiatrie|June 2, 2010
Immunity against tetanus and diphtheria after childhood sarcoma treatmentM Paulides, W Stöhr, H-Jürgen Laws, et al.
Medical and Pediatric Oncology|June 1, 1997
CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working GroupH Hertzberg, W J Huk, M A Ueberall, et al.
European Journal of Pediatrics|September 20, 1997
Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/BM A Ueberall, G Skirl, H M Strassburg, et al.
Journal of Medicinal Chemistry|March 26, 1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivativesA Cappelli, M Anzini, S Vomero, et al.
Pageof 19